The Facts About Supplements

Q: What are dietary supplements?

Dietary supplements, including plant- and animal-derived products, are not classified as or considered to be drugs, but that doesn’t mean they can’t act like them. To be classified as a dietary supplement, a product must be taken by mouth and contain a “dietary ingredient” —that is, a substance intended to be taken in addition to, not instead of, consuming healthy foods. Overall, dietary supplements include vitamins, minerals, botanicals, amino acids and any part of those substances, such as extracts or concentrates.

Friday, November 9 , 2007– Issue #218

eLetter Archive

Dr. Arnett Honored With Master Recognition to Rheumatology Field

Dr. Frank C. Arnett, Jr.

Frank C. Arnett, Jr., M.D., a member of the Scleroderma Foundation’s Medical Advisory Board, was recognized this week with a Master of the American College of Rheumatology during its 71st Annual Scientific Meeting.

The recognition is given to American College of Rheumatology members, age 65 or older, who have made outstanding contributions to the field of rheumatology through scholarly achievement and/or service to their patients, students and profession.

Dr. Arnett is professor of internal medicine and rheumatology at the University of Texas Medical School at Houston. Congratulations.

Foundation to Honor Three Doctors at National Gala

Three physicians will be honored Thursday, Nov. 29, when the Scleroderma Foundation holds its "Swing for the Stars" gala at the Grand Hyatt Hotel in New York City. Rheumatologist Lee Shapiro, M.D., and gastroenterologists Barry Jaffin, M.D. and Anthony Weiss, M.D., will be honored during the event that is being co-sponsored by the Foundation and its Tri-State Chapter.

One-Year Delay in Diagnosis Typical for Pulmonary Hypertension

A study shows that most patients experience a one-year delay between the onset of symptoms and a confirmed diagnosis of pulmonary arterial hypertension (PAH), researchers reported here at CHEST 2007, the scientific assembly of the American College of Chest Physicians.

The ongoing REVEAL study (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management) is a large database of 1,226 patients with PAH. More than half (60%) have co-morbidities, including hypertension (32%), depression (14%), hypothyroidism (6%), scleroderma (15%) and diabetes (13%).

(Medscape free registration)

Gilead Announces New Letairis(TM) (ambrisentan) Data for the Treatment of Patients with Pulmonary Arterial Hypertension (WHO Group 1)

New data from the Phase III ARIES studies evaluating ambrisentan in patients with pulmonary arterial hypertension (PAH) was recently presented at CHEST 2007, the annual meeting of the American College of Chest Physicians.

Upcoming Events

Scleroderma Foundation, 300 Rosewood Drive, Suite 105, Danvers, MA 01923
Phone 978-463-5843 · 800-722-HOPE (4673)

© Copyright 2001–2007 Scleroderma Foundation. All Rights Reserved.
Disclaimer. Privacy Policy. Webmaster